Conclusion The way GLP-1 therapies are used today reflects a major shift in diabetes care
Prime remains committed to studying the impact of GLP-1s for the foreseeable future because clients and patients deserve to make informed decisions, and our real-world data can help them do that, said Marci Chodroff, M.D., vice president and medical director at Prime
And freezing, while it preserves the unreconstituted powder, destroys the reconstituted solution by forming ice crystals that shear peptide molecules apart
For context, the placebo group in the same trial lost only 2.4%, making the drug-attributable weight loss approximately 12.5 percentage points
Most patients do not need to do the intensive weight loss plan, and that is only for specific cases, or temporary boosts, and then decreasing back down to the 0.5 mg to 1 mg range of healthy stable weight loss
this may be related to reduced caloric intake, though the precise cause is not fully established and persistent fatigue should be discussed with the trial team